AAAAAA

   
Results: 1-7 |
Results: 7

Authors: Markwalder, JA Mutlib, DDCA Cordova, BC Klabe, RM Seitz, SP
Citation: Ja. Markwalder et al., Synthesis and biological activities of potential metabolites of the non-nucleoside reverse transcriptase inhibitor efavirenz, BIOORG MED, 11(5), 2001, pp. 619-622

Authors: Corbett, JW Pan, SL Markwalder, JA Cordova, BC Klabe, RM Garber, S Rodgers, JD Erickson-Viitanen, SK
Citation: Jw. Corbett et al., 3,3a-Dihydropyrano[4,3,2-de]quinazolin-2(1H)-ones are potent non-nucleoside reverse transcriptase inhibitors, BIOORG MED, 11(2), 2001, pp. 211-214

Authors: Carini, DJ Kaltenbach, RF Liu, J Benfield, PA Boylan, J Boisclair, M Brizuela, L Burton, CR Cox, S Grafstrom, R Harrison, BA Harrison, K Akamike, E Markwalder, JA Nakano, Y Seitz, SP Sharp, DM Trainor, GL Sielecki, TM
Citation: Dj. Carini et al., Identification of selective inhibitors of cyclin dependent kinase 4, BIOORG MED, 11(16), 2001, pp. 2209-2211

Authors: Schwartz, B Markwalder, JA Wang, Y
Citation: B. Schwartz et al., Lipid II: Total synthesis of the bacterial cell wall precursor and utilization as a substrate for glycosyltransfer and transpeptidation by penicillinbinding protein (PBP) 1b of Eschericia coli, J AM CHEM S, 123(47), 2001, pp. 11638-11643

Authors: Mutlib, AE Gerson, RJ Meunier, PC Haley, PJ Chen, H Gan, LS Davies, MH Gemzik, B Christ, DD Krahn, DF Markwalder, JA Seitz, SP Robertson, RT Miwa, GT
Citation: Ae. Mutlib et al., The species-dependent metabolism of efavirenz produces a nephrotoxic glutathione conjugate in rats, TOX APPL PH, 169(1), 2000, pp. 102-113

Authors: Patel, M Ko, SS McHugh, RJ Markwalder, JA Srivastava, AS Cordova, BC Klabe, RM Erickson-Viitanen, S Trainor, GL Seitz, SP
Citation: M. Patel et al., Synthesis and evaluation of analogs of Efavirenz (SUSTIVA (TM)) as HIV-1 reverse transcriptase inhibitors, BIOORG MED, 9(19), 1999, pp. 2805-2810

Authors: Mutlib, AE Chen, H Nemeth, GA Markwalder, JA Seitz, SP Gan, LS Christ, DD
Citation: Ae. Mutlib et al., Identification and characterization of efavirenz metabolites by liquid chromatography/mass spectrometry and high field NMR: Species differences in the metabolism of efavirenz, DRUG META D, 27(11), 1999, pp. 1319-1333
Risultati: 1-7 |